GlassScriptPhysician profile
Trisha R Tyo
NPI 1003394834
$1,445.70
in general payments reported to CMS, 2019-2025
12 companies · $507 in 2025
The $507 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $240 · 2023: $329 · 2024: $258 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017 · Travel and Lodging: $76.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.01 |
| Travel and Lodging | $76.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $233.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Avita Medical Americas, LLC | $212.18 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Stryker Corporation | $177.07 | 2023-2025 | Na, Dermacell |
| Kci USA, INC. | $174.51 | 2022 | |
| Medical Device Business Services, INC. | $143.85 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $125.50 | 2024 | |
| Solventum Corporation | $110.05 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Mentor Worldwide LLC | $84.81 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $79.45 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Motiva USA, LLC | $70.79 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $19.98 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trisha Tyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.